Anzeige
Mehr »
Login
Samstag, 05.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Achtung Vervielfachung! URAN-AKTIEN starten durch …. Jetzt kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0F7BK | ISIN: FR0010220475 | Ticker-Symbol: AOMD
Tradegate
04.10.24
21:51 Uhr
19,560 Euro
+0,030
+0,15 %
1-Jahres-Chart
ALSTOM SA Chart 1 Jahr
5-Tage-Chart
ALSTOM SA 5-Tage-Chart
RealtimeGeldBriefZeit
19,39519,56513:04
19,48019,57504.10.
GlobeNewswire (Europe)
333 Leser
Artikel bewerten:
(2)

ALSTOM SA: Alstom Note - Q1 2024/25 Preview

Alstom Note - Q1 2024/25 Preview

5 July 2024 - Alstom presents below a preview to its Q1 2024/25 orders and sales results.

Q1 2024/25 Orders

The table below summarizes the large orders (more than €200 million) published and booked during the quarter.

Orders

Value
(in € million)
Description Link to press release
Undisclosed customer ~400 12 years Services order in AMECA region Link
Polo Logistica FS 323 70 TRAXX locomotives Link
Undisclosed customer 670 Rolling stock and signaling for a European customer Link
Elizabeth line 430 10 trains for Elizabeth Line in UK + maintenance Link
Total large orders ~1,823
  • Deals announced previously, but to be booked at a later stage
  • Haifa-Nazareth Systems contract for ~€700 million, expected booking in FY 2025/26: link to the press release
  • CP (Portugal) for ~€700 million, awarded to Alstom. Expecting end of competitors' challenge. Expected booking in FY 2024/25.
  • Toronto electrification for several € billions. Preliminary design works on-going (joint development phase). Bookings are expected in several batches from calendar year 2025 to 2028.
  • Focus on base orders

In addition to large orders disclosed in the above table, we remind the guidance for base orders (less than €200 million) which typically account for €1.5 billion to €2.0 billion per quarter since the merger with Bombardier.

The table below reminds the breakdown between large and base orders during Q1 for the last three fiscal years:

Q1 orders (in € billion) FY 2021/22 FY 2022/23 FY 2023/24
Base orders (less than €200m) 1.7 1.7 1.8
Large orders (more than €200m) 4.7 3.9 2.1
Total order intake 6.4 5.6 3.9
  • Reminder - FY 2024/25 guidance on orders

At FY 2023/24 release on 8 May 2024:

  • Book-to-bill ratio above 1 for FY 2024/25 at Group level, with an expected higher order intake during second half of the year versus first half.
  • Book-to-bill ratio for Rolling Stock to be around 1 for the three years FY 204/25 to FY 2026/27.

***

Q1 2024/25 Sales

At FY 2023/24 release on 8 May 2024:

  • We guided for an organic growth around 5% for FY 2024/25 at Group level
  • We reminded of usual seasonality (Q1 2024/25 growth to be measured against last fiscal year Q1)

Breakdown of sales by currency is given in the appendix of the FY 2024/25 analysts presentation (page 42): link to the presentation.

We expect small positive forex impact on sales of ~0.2% for the first quarter of FY 2024/25.

We expect negative perimeter impact on Q1 2024/25 sales for ~ (0.4)% due to a change in control of two service JVs with RENFE in Spain, following changes in the JV agreements: these JVs will now be accounted for under the equity method and no more as joint operations.

Reminder of other elements of guidance for FY 2024/25

  • aEBIT margin around 6.5 %
  • FCF generation €300m to €500m
  • Seasonality driving:
    • Negative FCF within a range of €(300)m to €(500)m in H1 2024/25
    • aEBIT margin development to be more H2 weighted

***

What to expect from July 23 release (at 6pm CET)

  • Reported Q1 orders and sales for FY 2024/25
  • Update on deleveraging plan
  • Guidance for FY 2024/25





Alstom





Alstom commits to contribute to a low carbon future by developing and promoting innovative and sustainable transportation solutions that people enjoy riding. From high-speed trains, metros, monorails, trams, to turnkey systems, services, infrastructure, signalling and digital mobility, Alstom offers its diverse customers the broadest portfolio in the industry. With its presence in 64 countries and a talent base of over 84,700 people from 184 nationalities, the company focuses its design, innovation, and project management skills to where mobility solutions are needed most. Listed in France, Alstom generated revenues of €17.6 billion for the fiscal year ending on 31 March 2024.
For more information, please visit www.alstom.com.
Contacts

Investor Relations
Martin VAUJOUR - Tel.: +33 (0) 6 88 40 17 57
martin.vaujour@alstomgroup.com



Estelle MATURELL ANDINO - Tél.: +33 (0) 6 71 37 47 56
estelle.maturell@alstomgroup.com





This document contains forward-looking statements which are based on current plans and forecasts of Alstom's management. Such forward-looking statements are relevant to the current scope of activity and are by their nature subject to a number of important risks and uncertainty factors (such as those described in the documents filed by Alstom with the French AMF) that could cause actual results to differ from the plans, objectives and expectations expressed in such forward-looking statements. These such forward-looking statements speak only as of the date on which they are made, and Alstom undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

This document does not constitute or form part of a prospectus or any offer or invitation for the sale or issue of, or any offer or inducement to purchase or subscribe for, or any solicitation of any offer to purchase or subscribe for any shares or other securities in the Company in France, the United Kingdom, the United States or any other jurisdiction. Any offer of the Company's securities may only be made in France pursuant to a prospectus having received the visa from the AMF or, outside France, pursuant to an offering document prepared for such purpose. The information does not constitute any form of commitment on the part of the Company or any other person. Neither the information nor any other written or oral information made available to any recipient or its advisers will form the basis of any contract or commitment whatsoever. In particular, in furnishing the information, the Company, its affiliates, shareholders, and their respective directors, officers, advisers, employees or representatives undertake no obligation to provide the recipient with access to any additional information.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.